Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges
- PMID: 33098549
- PMCID: PMC7585350
- DOI: 10.1007/s11684-020-0823-4
Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges
Conflict of interest statement
Tangchun Wu declares that he has no conflict of interest. This manuscript does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.
Comment on
-
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.Front Med. 2020 Dec;14(6):746-751. doi: 10.1007/s11684-020-0822-5. Epub 2020 Oct 5. Front Med. 2020. PMID: 33017040 Free PMC article.
References
-
- Mulligan MJ. JAMA. 2020. An inactivated virus candidate vaccine to prevent COVID-19. - PubMed
-
- Stephens DS, McElrath MJ. COVID-19 and the path to immunity. 2020. - PubMed
-
- To KK, Hung IF, Ip JD, Chu AW, Chan WM, Tam AR, Fong CH, Yuan S, Tsoi HW, Ng AC, Lee LL, Wan P, Tso E, To WK, Tsang D, Chan KH, Huang JD, Kok KH, Cheng VC, Yuen KY. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. 2020. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
